Some studies have consistently shown that CCNE1 is associated with disease progression in various malignancies and is clinically associated with poor prognosis in patients with ovarian, breast, bladder and colorectal cancer [39–42]. This evidence concerns the gene CCNE1 and colorectal cancer.